Philogen is a biotechnology company that focuses on innovating the treatment of cancer and other serious conditions. self-described as Swiss-Italian.

Philogen

Chiesi Farmaceutici S.p.A is involved in the pharmaceutical sector, focusing on respiratory therapies and healthcare research and development. The company provides innovative solutions and collaborates with other organizations for the development of its products.

Chiesi Farmaceutici S.p.A

Olympus Italia develops customer-oriented solutions for the medical sector. The company has been committed to making people's lives healthier, safer, and more rewarding for over 100 years. Self-described as focused on advancing medical technology.

Metric
Company Name	Philogen	Chiesi Farmaceutici S.p.A	Olympus Italia
Symbol
MSH ID	COM:PHILOGEN	COM:CHIESI	IT:OLYMPUS
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Biotechnology	Pharmaceuticals	Medical Devices
Country	IT	IT	IT
Stage			Post-IPO Equity
Employee Count
Website	philogen.com	chiesi.com	olympus.it
LinkedIn			olympus-italy
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic			132.60K
Web Traffic Growth			-0.15
Valuation
Raised Capital			600M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:PHILOGEN

Philogen

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue